Literature DB >> 7784084

Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.

A Zauberman1, A Lupo, M Oren.   

Abstract

An immune-selection procedure was employed in order to isolate p53-binding sites from rat genomic DNA. One such site was found to reside within the first intron of the cyclin G gene. Cyclin G mRNA levels are strongly elevated upon induction of wild type p53 activity in cells carrying a temperature sensitive p53 mutant. The cyclin G gene also carries a second p53-binding motif upstream to its transcriptional start site. The presence of two high affinity p53-binding sites may confer upon the cyclin G gene the potential to be activated very efficiently by p53. These data raise the possibility that cyclin G may be a downstream mediator of at least some of the biological effects of p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7784084

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.

Authors:  E Gottlieb; R Haffner; A King; G Asher; P Gruss; P Lonai; M Oren
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

2.  Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells.

Authors:  Dakang Xu; Trevor J Wilson; David Chan; Elisabetta De Luca; Jiong Zhou; Paul J Hertzog; Ismail Kola
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

3.  PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development.

Authors:  Zhigang Jin; Lindsay Wallace; Scott Q Harper; Jing Yang
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

4.  Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

Authors:  G Farmer; P Friedlander; J Colgan; J L Manley; C Prives
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

5.  Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.

Authors:  Aruni S Arachchige Don; Robert F Dallapiazza; David A Bennin; Tiffany Brake; Colleen E Cowan; Mary C Horne
Journal:  Exp Cell Res       Date:  2006-09-29       Impact factor: 3.905

6.  p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene.

Authors:  A Hari Kishore; Kiran Batta; Chandrima Das; Shipra Agarwal; Tapas K Kundu
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

7.  p53-independent cyclin G expression in a group of mature neurons and its enhanced expression during nerve regeneration.

Authors:  N Morita; S Kiryu; H Kiyama
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

8.  A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis.

Authors:  P Friedlander; Y Haupt; C Prives; M Oren
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

9.  p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A.

Authors:  K Okamoto; C Kamibayashi; M Serrano; C Prives; M C Mumby; D Beach
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

10.  A better cell cycle target for gene therapy of colorectal cancer: cyclin G.

Authors:  Rodrigo Perez; Nancy Wu; Adam A Klipfel; Robert W Beart
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.